Screening for pancreatic cancer in high-risk people
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial uses MRI and endoscopic ultrasound to look for early signs of pancreatic cancer in people who have a high risk due to their genes or family history. Finding it early may lead to better treatment options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Have a gene change (like in STK11, CDKN2A, ATM, BRCA1, BRCA2, or others) that raises pancreatic cancer risk, and be over a certain age.
- OR have a strong family history of pancreatic cancer (for example, two or more close relatives on the same side of the family).
- OR have a gene change in PRSS1 that causes hereditary pancreatitis, and be over age 40 (or 20 years after pancreatitis started).
- Be healthy enough to undergo an MRI and an endoscopic ultrasound.
- Not have current or past pancreatic cancer or any other active cancer that has spread.
- Be at least 18 years old and able to give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study screens people at high risk for pancreatic cancer using imaging tests. It aims to catch cancer early in those with certain genetic conditions or strong family history.
This trial tests ways to screen people who have a family-passed (inherited) gene mutation linked to higher pancreatic cancer risk. The goal is to find pancreatic cancer earlier and improve how screening is done for people at increased risk.
This trial uses an artificial-intelligence tool to help detect pancreatic cancer earlier and track people at higher risk. You may be asked to complete questionnaires and have imaging tests like MRI or CT to see how well the approach works.
This study builds a database of people at higher risk for pancreatic cancer (or certain early warning findings) to help find better ways to detect the disease early. You may be asked to complete health questionnaires and possibly donate a blood/saliva/swab sample.
This study screens people with recent diabetes who are at high risk for pancreatic cancer. It uses a CT scan to find cancer early, when it may be easier to treat.
This early-phase trial studies a long-peptide vaccine designed for people with certain genetic changes that raise the risk of pancreatic cancer. The goal is to help your immune system recognize and respond to cancer-related changes before cancer develops.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.